Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors
University of California, San Francisco
University of California, San Francisco
INSYS Therapeutics Inc
Memorial Sloan Kettering Cancer Center
Novartis
National Cancer Institute (NCI)
National Cancer Institute (NCI)